Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid And Liquid), End User (Hospitals & Clinics, Research Centers, And Others) - Americas Forecast Till 2023

Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid And Liquid), End User (Hospitals & Clinics, Research Centers, And Others) - Americas Forecast Till 2023


  • Products Id :- MRFR/HC/4106-CRR
  • |
  • Pages: 90
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

This report will be delivered within 24-48 hours (excluding weekends) of the purchase.

Executive Summary

Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals & Clinics, Research Centers, And Others)-Americas Forecast Till 2023

Market Analysis

In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD influences up to 40% of the U.S. populace in their lifetime and currently, most of the people are facing this health condition. If the GERD isn't appropriately overseen, it can prompt Barrett's esophagus. Early treatment of Barrett's esophagus is significant in light of the fact that it is the essential risk factor for esophageal cancer. The frequency of indigestion issue, otherwise called acid reflux, is quickly expanding around the world. According to various studies almost each individual experiences acid reflux at least once in their lifetime. GERD is one of the regularly watched intermittent gastrointestinal disorders around the world. The Americas GERD & NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.

This issue not just affects the health and nature of patient lives yet, in addition, stretches out to the healthcare economy and system. The real driving elements for the development of the market are expanding instances of smoking, rising instances of reflux issue amid pregnancy, evolving way of life, and sporadic dietary propensities. In addition, expanding occurrence of indigestion issue (acid reflux), developing geriatric populace is probably going to fuel the market development.

Market Segmentation

The Americas GERD & NERD treatment market is classified on the basis of its drug class, end user, dosage form, and regional analysis. Based on its drug class, the market is bifurcated into proton pump inhibitors, antacids (acid neutralizers), H2 receptor blocker, antidepressants, prokinetic agents, calcium channel blockers, among others. On the basis of its dosage form, the Americas GERD & NERD treatment market is divided into liquid and solid. Based on its end-user industry, the global market is segmented into research centers, hospitals & clinics, and others.

Regional Analysis

Geographically, the Americas GERD & NERD treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Industry Players

The list of major players in the Americas GERD & NERD treatment market include companies like AstraZeneca Plc (U.K), Cempra Inc. (U.S.), Boston Scientific Corporation (U.S.), Eisai Co., Ltd. (Japan), EndoStim Inc. (U.S.), EndoGastric Solutions Inc. (U.S.), GlaxoSmithKline Plc (U.K), Jeil Pharmaceutical Co. Ltd. (South Korea), Ironwood Pharmaceuticals, Inc. (U.S.), Johnson & Johnson (U.S.), Medigus Ltd. (Israel), Mederi Therapeutics Inc. (U.S.), Medtronic Inc. (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), among others.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1.1 Primary Research Methodology

3.1.2 Data Points Received from the Doctors/ Gastrologist:

3.1.3 Data points received from the Manufacturer/ Pharmaceutical Companies:

3.1.4 Data points received from Hospitals, Clinics:

3.1.5 Secondary Research Methodology

3.1.6 Market Share Analysis

3.1.7 Trade Analysis

3.1.8 Market Pricing Approach

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing cases of smoking to boost the market growth (Impact weightage- 20%)

4.2.2 Rising cases of reflux disorder during pregnancy (impact weightage- 15%)

4.2.3 Changing lifestyle and irregular dietary habits (Impact weightage- 15%)

4.2.4 Increasing incidence of acid reflux disorder (heartburn) will boost the American GERD& NERD treatment market (Impact weightage- 25%)

4.2.5 Growing geriatric population (impact weightage- 15%)

4.2.6 Increasing demands for endoscopy biopsy procedures for early diagnosis (Impact weightage- 10%)

4.3 Restraints

4.3.1 Loss of patent exclusivity and lack of pipeline drugs (impact weightage- 55%)

4.3.2 High cost of the gastroscopes (weightage impact- 45%)

4.4 Opportunity

4.4.1 Development of new drugs

4.5 Mega Trends

4.6 Macroeconomic Indicators

4.7 Technology Trends & Assessment

5 Market Factor Analysis

5.1 Porters Five forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Monitoring

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

6 Americas GERD & NERD Treatment Market, by Drug class

6.1 Introduction

6.2 Antacids (Acid Neutralizers)

6.3 Proton Pump Inhibitors

6.3.1 Esomeprazole

6.3.2 Omeprazole

6.3.3 Pantoprazole

6.3.4 Lansoprazole

6.3.5 Dexlansoprazole

6.3.6 Rabeprazole

6.4 H2 receptor blocker

6.4.1 Ranitidine

6.4.2 Famotidine

6.4.3 Cimetidine

6.4.4 Nizatidine

6.5 Pro kinetic agents

6.5.1 Domperidone

6.5.2 Metoclopramide

6.5.3 Itopride

6.5.4 Prucalopride

6.5.5 Cisapride

6.5.6 Benzamide

6.5.7 Mosapride

6.5.8 Erythromycin

6.6 Antidepressants

6.7 Calcium Channel Blockers

7 Americas GERD & NERD Treatment Market, by Dosage Form

7.1 Introduction

7.2 Solid

7.3 Liquid

8 Americas GERD & NERD Treatment Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Research Centers

9 Americas GERD & NERD Treatment Market, by Region

10 Americas GERD & NERD Treatment Market, by Region

10.1 Introduction

10.2 North America

10.2.1 U.S.

10.2.2 Canada

10.3 South America

11 Competitive Landscape

11.1 Introduction

11.2 Company Share Analysis

12 Company Profiles

12.1 AstraZeneca

12.1.1 Company Overview

12.1.2 Financials

12.1.3 Products

12.1.4 Strategy

12.1.5 Key Developments

12.2 Addex Pharmaceuticals

12.2.1 Company Overview

12.2.2 Financials

12.2.3 Products

12.2.4 Strategy

12.2.5 Key Developments

12.3 Takeda Pharmaceutical

12.3.1 Company Overview

12.3.2 Financials

12.3.3 Products

12.3.4 Strategy

12.3.5 Key Developments

12.4 Eisai Co., Ltd

12.4.1 Company Overview

12.4.2 Financials

12.4.3 Products

12.4.4 Strategy

12.4.5 Key Developments

12.5 Medigus Ltd

12.5.1 Company Overview

12.5.2 Financials

12.5.3 Products

12.5.4 Strategy

12.5.5 Key Developments

12.6 RaQualia Pharma Inc

12.6.1 Company Overview

12.6.2 Financials

12.6.3 Products

12.6.4 Strategy

12.6.5 Key Developments

12.7 Torax Medical

12.7.1 Company Overview

12.7.2 Financials

12.7.3 Products

12.7.4 Strategy

12.7.5 Key Developments

12.8 Carbon Medical technologies

12.8.1 Company Overview

12.8.2 Financials

12.8.3 Products

12.8.4 Strategy

12.8.5 Key Developments

12.9 Endogastric Solutions

12.9.1 Company Overview

12.9.2 Financials

12.9.3 Products

12.9.4 Strategy

12.9.5 Key Developments

12.1 Medtronic

12.10.1 Company Overview

12.10.2 Financials

12.10.3 Products

12.10.4 Strategy

12.10.5 Key Developments

12.11 Pfizer

12.11.1 Company Overview

12.11.2 Financials

12.11.3 Products

12.11.4 Strategy

12.11.5 Key Developments

12.12 Novartis AG.

12.12.1 Company Overview

12.12.2 Financials

12.12.3 Products

12.12.4 Strategy

12.12.5 Key Developments

12.13 GlaxoSmithKline plc

12.13.1 Company Overview

12.13.2 Financials

12.13.3 Products

12.13.4 Strategy

12.13.5 Key Developments

12.14 Valeant Pharmaceuticals

12.14.1 Company Overview

12.14.2 Financials

12.14.3 Products

12.14.4 Strategy

12.14.5 Key Developments

12.15 Ironwood Pharmaceuticals, Inc.

12.15.1 Company Overview

12.15.2 Financials

12.15.3 Products

12.15.4 Strategy

12.15.5 Key Developments

13 Appendix

13.1 Discussion Blue Print

14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO's View Point

14.1.2 Unmet Needs

14.2 Key companies to watch

List of Figures:

FIGURE 1 AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2016 (%)

FIGURE 2 AMERICAS GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2016 (%)

FIGURE 3 AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2016 (%)

FIGURE 4 MARKET STRUCTURE

FIGURE 5 RESEARCH METHODOLOGY

FIGURE 6 DATA TRIANGULATION PRIMARY

FIGURE 7 DATA TRIANGULATION METHOD

FIGURE 8 PORTER'S FIVE FORCES MODEL

FIGURE 9 AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2016 & 2023 (USD MILLION)

FIGURE 10 AMERICAS GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2016 & 2023 (USD MILLION)

FIGURE 11 AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2016 & 2023 (USD MILLION)

FIGURE 12 AMERICAS GERD & NERD TREATMENT MARKET, BY REGION, 2016 & 2023 (USD MILLION)

List of Tables:

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 AMERICAS GERD & NERD TREATMENT MARKET, BY ANTACIDS (ACID NEUTRALIZERS), 2014-2023 (USD MILLION)

TABLE 3 AMERICAS GERD & NERD TREATMENT MARKET, BY PROTON PUMP INHIBITORS, 2014-2023 (USD MILLION)

TABLE 4 AMERICAS GERD & NERD TREATMENT MARKET, BY ESOMEPRAZOLE, 2014-2023 (USD MILLION)

TABLE 5 AMERICAS GERD & NERD TREATMENT MARKET, BY OMEPRAZOLE, 2014 TO 2023 (USD MILLION)

TABLE 6 AMERICAS GERD & NERD TREATMENT MARKET, BY PANTOPRAZOLE, 2014 TO 2023 (USD MILLION)

TABLE 7 AMERICAS GERD & NERD TREATMENT MARKET, BY LANSOPRAZOLE, 2014 TO 2023 (USD MILLION)

TABLE 8 AMERICAS GERD & NERD TREATMENT MARKET, BY DEXLANSOPRAZOLE, 2014 TO 2023 (USD MILLION)

TABLE 9 AMERICAS GERD & NERD TREATMENT MARKET, BY RABEPRAZOLE, 2014 TO 2023 (USD MILLION)

TABLE 10 AMERICAS GERD & NERD TREATMENT MARKET, BY H2 RECEPTOR BLOCKER, 2014 TO 2023 (USD MILLION)

TABLE 11 AMERICAS GERD & NERD TREATMENT MARKET, BY RANITIDINE, 2014 TO 2023 (USD MILLION)

TABLE 12 AMERICAS GERD & NERD TREATMENT MARKET, BY FAMOTIDINE, 2014 TO 2023 (USD MILLION)

TABLE 13 AMERICAS GERD & NERD TREATMENT MARKET, BY CIMETIDINE, 2014 TO 2023 (USD MILLION)

TABLE 14 AMERICAS GERD & NERD TREATMENT MARKET, BY NIZATIDINE, 2014 TO 2023 (USD MILLION)

TABLE 15 AMERICAS GERD & NERD TREATMENT MARKET, BY PRO KINETIC AGENTS, 2014-2023 (USD MILLION)

TABLE 16 AMERICAS GERD & NERD TREATMENT MARKET, BY DOMPERIDONE, 2014 TO 2023 (USD MILLION)

TABLE 17 AMERICAS GERD & NERD TREATMENT MARKET, BY METOCLOPRAMIDE, 2014 TO 2023 (USD MILLION)

TABLE 18 AMERICAS GERD & NERD TREATMENT MARKET, BY ITOPRIDE, 2014 TO 2023 (USD MILLION)

TABLE 19 AMERICAS GERD & NERD TREATMENT MARKET, BY PRUCALOPRIDE, 2014 TO 2023 (USD MILLION)

TABLE 20 AMERICAS GERD & NERD TREATMENT MARKET, BY CISAPRIDE, 2014 TO 2023 (USD MILLION)

TABLE 21 AMERICAS GERD & NERD TREATMENT MARKET, BY BENZAMIDE, 2014 TO 2023 (USD MILLION)

TABLE 22 AMERICAS GERD & NERD TREATMENT MARKET, BY MOSAPRIDE, 2014 TO 2023 (USD MILLION)

TABLE 23 AMERICAS GERD & NERD TREATMENT MARKET, BY ERYTHROMYCIN, 2014 TO 2023 (USD MILLION)

TABLE 24 AMERICAS GERD & NERD TREATMENT MARKET, BY ANTIDEPRESSANTS, 2014 TO 2023 (USD MILLION)

TABLE 25 AMERICAS GERD & NERD TREATMENT MARKET, BY CALCIUM CHANNEL BLOCKERS, 2014 TO 2023 (USD MILLION)

TABLE 26 AMERICAS GERD & NERD TREATMENT MARKET, BY SOLID, 2014 TO 2023 (USD MILLION)

TABLE 27 AMERICAS GERD & NERD TREATMENT MARKET, BY LIQUID, 2014 TO 2023 (USD MILLION)

TABLE 28 AMERICAS GERD & NERD TREATMENT MARKET, BY HOSPITALS & CLINICS, 2014 TO 2023 (USD MILLION)

TABLE 29 AMERICAS GERD & NERD TREATMENT MARKET, BY RESEARCH CENTERS, 2014 TO 2023 (USD MILLION)

TABLE 30 AMERICAS GERD & NERD TREATMENT MARKET, BY REGION, 2014 TO 2023 (USD MILLION)

TABLE 31 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2014-2023 (USD MILLION)

TABLE 32 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 33 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 34 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 35 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2014-2023 (USD MILLION)

TABLE 36 NORTH AMERICA GERD & NERD TREATMENT MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 37 U.S. GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2014-2023 (USD MILLION)

TABLE 38 U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 39 U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 40 U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 41 U.S. GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2014-2023 (USD MILLION)

TABLE 42 U.S. GERD & NERD TREATMENT MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 43 CANADA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2014-2023 (USD MILLION)

TABLE 44 CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 45 CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 46 CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 47 CANADA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2014-2023 (USD MILLION)

TABLE 48 CANADA GERD & NERD TREATMENT MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 49 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2014-2023 (USD MILLION)

TABLE 50 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 51 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 52 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 53 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2014-2023 (USD MILLION)

TABLE 54 SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY END USER, 2014-2023 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

AstraZeneca Plc (U.K), Cempra Inc. (U.S.), Boston Scientific Corporation (U.S.), Eisai Co., Ltd. (Japan), EndoStim Inc. (U.S.), EndoGastric Solutions Inc. (U.S.), GlaxoSmithKline Plc (U.K), Jeil Pharmaceutical Co. Ltd. (South Korea), Ironwood Pharmaceuticals, Inc. (U.S.), Johnson & Johnson (U.S.), Medigus Ltd. (Israel), Mederi Therapeutics Inc. (U.S.), Medtronic Inc. (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), among others.

select a license
Single User License
USD 4450 INR 311500
Corporate User License
USD 6250 INR 437500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com